Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eliezer Huberman is active.

Publication


Featured researches published by Eliezer Huberman.


Cancer Letters | 1979

The importance of the "bay region" diol-epoxide in 7,12-dimethylbenz[a]anthracene skin tumor initiation and mutagenesis.

Thomas J. Slaga; Eliezer Huberman; J. DiGiovanni; G. L. Gleason; Ronald G. Harvey

The skin tumor-initiating and V79 mutagenic activities of various derivatives of 7,12-dimethylbenz[a]anthracene (DMBA) were investigated to determine what possible cellular metabolite(s) may be responsible for its carcinogenicity and/or mutagenicity. 1-,2-,3-,4- and 5-hydroxyDMBA were found to be essentially inactive as skin tumor initiators whereas 9- and 10-hydroxyDMBA had weak activity. The (+/-)-trans DMBA 8,9- and 5,6-dihydrodiols were also essentially inactive as skin tumor initiators and (+/-)-DMBA 8beta,9alpha-diol-10alpha-11alpha-epoxide had weak skin tumor initiating activity. All of the above tested derivatives of DMBA were essentially inactive as mutagens in the cell-mediated or direct V79 mutagenesis systems. A methyl or fluoro addition to the 1, 2 or 5 positions almost completely blocked the skin tumor initiating and V79 mutagenic activities of DMBA, whereas a fluoro addition to position 11 did not. From our data we suggest that a bay region diol-epoxide may be important in DMBA carcinogenicity and mutagenicity.


Cancer Letters | 1978

Mutagenicity to mammalian cells in culture by (+) and (−) trans-7, 8-dihydroxy-7, 8-dihydrobenzo(a)pyrenes and the hydrolysis and reduction products of two stereoisomeric benzo(a)pyrene 7, 8-diol-9, 10-epoxides

Eliezer Huberman; Shen K. Yang; David W. McCourt; Harry V. Gelboin

The mutagenicity for mammalian cells of benzo(a)pyrene (BP) and 9 of its derivatives was tested by resistance to ouabain in Chinese hamster V78 cells. The derivatives included the (-) and (+) enantiomers of trans-7,8-diol; the racemic (+/-)trans-7,8-diol; two triols, (7/8,9)-triol and (7,9/8)-triol; and four tetrols, (7,10/8,9)-tetrol, (7/8,9,10)-tetrol, (7,9/8,10-triol and (7,9,10/8)-tetrol. Since V78 cells do not metabolize polycyclic hydrocarbons, mutagenesis was tested both in the presence and in the absence of Golden hamster cells capable of metabolizing polycyclic hydrocarbons. Neither BP nor any of its 9 tested derivatives showed mutagenicity for V78 cells in the absence of normal Golden hamster cells. However, in the presence of these cells, BP and the optically active and racemic trans-7,8-diols exhibited a mutagenic response that was dose-dependent. All other derivatives were inactive. The most active mutagenic hydrocarbon was (-) trans-7,8-diol, and activity decreased in the order (+/-)trans-7,8-diol, (+) trans-7,8-diol and BP.


Basic life sciences | 1983

Studies on the Mode of Action of Chemical Carcinogens in Cultured Mammalian Cells

Carol Jones; Eliezer Huberman

Researchers estimate that environmental chemicals are responsible for a portion of human cancers. These chemicals, identified as potential carcinogens by epidemiology or experimental studies, constitute a very diverse group and thus are likely to interact in the carcinogenic process at different stages and to varying degrees.


Archive | 1978

Mutagenesis of Mammalian Cells by Chemical Carcinogens after Metabolic Activation

Eliezer Huberman; Robert Langenbach

Currently there is an increased interest in developing short-term bioassays for carcinogens in view of the studies which implicate a large number of environmental chemicals in causing cancer. While the mechanism by which chemicals induce cancer is unknown, one of the simplest explanations is that carcinogenesis is initiated by a somatic mutation. Indeed, chemical carcinogens are capable of binding to the DNA of susceptible mammalian cells (1–6), and can induce mutations at different genetic loci (25). Some of these mutations could also involve the genes that control the expression of malignant transformation (7–10). Studies of the mutagenic activity of carcinogens in mammalian cells should therefore provide an important technique for detecting cancer-causing agents and possibly for elucidating the mechanism of carcinogenesis (10–15). However, most compounds encountered in the environment are chemically nonreactive and have to be enzymatically activated before they can manifest biological activity (16–17). Furthermore, many mammalian cell lines which are suitable for studies on mutagenesis are not able to metabolically activate these chemicals (18–22).


Proceedings of the National Academy of Sciences of the United States of America | 1981

Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyelocytic leukemia cells

Eliezer Huberman; Charles Weeks; Adria Herrmann; Michael F. Callaham; Thomas J. Slaga


Cancer Research | 1978

Carcinogenicity and Mutagenicity of Benz(a)anthracene Diols and Diol-Epoxides

Thomas J. Slaga; Eliezer Huberman; James K. Selkirk; Ronald G. Harvey; W. M. Bracken


Cancer Research | 1979

Mutagenicity and Tumor-initiating Activity of Fluorinated Derivatives of 7,12-Dimethylbenz(a)anthracene

Eliezer Huberman; Thomas J. Slaga


Cancer Research | 1980

Alterations in Lipid Metabolism Induced by 12-O-Tetradecanoylphorbol-13-acetate in Differentiating Human Myeloid Leukemia Cells

Myles C. Cabot; Clement J. Welsh; Michael F. Callaham; Eliezer Huberman


Carcinogenesis | 1982

Induction of differentiation of human promyelocytic leukemia (HL-60) cells by teleocidin and phorbol-12-myristate-13-acetate

Eliezer Huberman; Gary R. Braslawsky; Michael F. Callaham; Hirota Fugiki


Proceedings of the National Academy of Sciences of the United States of America | 1979

Identification of 7,12-dimethylbenz[a]anthracene metabolites that lead to mutagenesis in mammalian cells.

Eliezer Huberman; Ming W. Chou; Shen K. Yang

Collaboration


Dive into the Eliezer Huberman's collaboration.

Top Co-Authors

Avatar

Thomas J. Slaga

Cosmetic Ingredient Review

View shared research outputs
Top Co-Authors

Avatar

Michael F. Callaham

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Carol Jones

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shen K. Yang

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Adria Herrmann

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Charles Weeks

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Clement J. Welsh

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

David W. McCourt

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

G. L. Gleason

Oak Ridge National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge